NORGES BANK

Q3 2021 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Stanislav Boiadjiev - Lead Regulatory Compliance Advisor
Location
Oslo, Norway
Holdings as of
September 30, 2021
Value $
$452B
Num holdings
2,270
Date filed
11/14/2022, 09:01 AM
Description
Request for Confidential Treatment (11/5/2021): Confidential Treatment Expired on 11/14/2022. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2021 - Aug 10, 2021
Next filing
Q4 2021 - Feb 10, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 11-05-2021 pursuant to a request for confidential treatment and for which confidential treatment expired on 11-14-2022.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Stanislav Boiadjiev Lead Regulatory Compliance Advisor Oslo, Norway 11/14/2022

Collateral received through secured lending and borrowing transactions in the form of securities, where Norges Bank has the right to sell or pledge the security, is not recognized in its balance sheet unless reinvested. Correspondingly, such collateral is not reflected in our 13F reporting.